These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 18041667)

  • 41. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Challenges of cancer biomarker profiling.
    Bensalah K; Montorsi F; Shariat SF
    Eur Urol; 2007 Dec; 52(6):1601-9. PubMed ID: 17919807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biomarkers in translational research: focus on discovery, development and translation of protein biomarkers to clinical immunoassays.
    Rai AJ
    Expert Rev Mol Diagn; 2007 Sep; 7(5):545-53. PubMed ID: 17892363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer biomarkers--an invitation to the table.
    Dalton WS; Friend SH
    Science; 2006 May; 312(5777):1165-8. PubMed ID: 16728629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.
    Flaig TW; Nordeen SK; Lucia MS; Harrison GS; Glodé LM
    J Urol; 2007 Apr; 177(4):1229-37. PubMed ID: 17382696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolomics in cancer: a bench-to-bedside intersection.
    Claudino WM; Goncalves PH; di Leo A; Philip PA; Sarkar FH
    Crit Rev Oncol Hematol; 2012 Oct; 84(1):1-7. PubMed ID: 22429650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molecular-target drug].
    Sone S; Yano S; Nishioka Y
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1034-40. PubMed ID: 15272581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein arrays for biomarker discovery.
    Reid JD; Parker CE; Borchers CH
    Curr Opin Mol Ther; 2007 Jun; 9(3):216-21. PubMed ID: 17608019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis.
    Lee JW; Hall M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1259-71. PubMed ID: 19038585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential of urinary biomarkers in early bladder cancer diagnosis.
    Lam T; Nabi G
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1105-15. PubMed ID: 18028019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery and development of biomarkers of neurological disease.
    Dunckley T; Coon KD; Stephan DA
    Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
    Cho WC
    Biomed Pharmacother; 2007 Oct; 61(9):515-9. PubMed ID: 17913444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ; Bernhard OK; Greening DW; Moritz RL
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical biomarkers of kinase activity: examples from EGFR inhibition trials.
    Krause M; Baumann M
    Cancer Metastasis Rev; 2008 Sep; 27(3):387-402. PubMed ID: 18427731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genomics and proteomics: emerging technologies in clinical cancer research.
    Chung CH; Levy S; Chaurand P; Carbone DP
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncoproteomics.
    Joshi S; Tiwari AK; Mondal B; Sharma A
    Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical biomarkers in drug discovery and development.
    Frank R; Hargreaves R
    Nat Rev Drug Discov; 2003 Jul; 2(7):566-80. PubMed ID: 12838269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.